Related Experiment Video
Updated: Jul 5, 2025

07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
Evaluation of a COVID-19 Risk Tool
Sue S Feldman1, Abdulaziz Ahmed1, Justine Maxwell1
1University of Alabama at Birmingham, Birmingham, Alabama, USA.
Studies in Health Technology and Informatics
|January 25, 2024
Summary
A new tool was developed to track COVID-19 symptoms and assess risk for returning to work. Early evaluation shows its potential for managing workplace safety and enabling a return to normalcy.
Area of Science:
- Public Health
- Health Informatics
- Occupational Health
Background:
- The COVID-19 pandemic highlighted challenges in monitoring symptoms within educational and work environments.
- Technological solutions are crucial for mitigating pandemic impacts by guiding behavior and reducing disease exposure.
- Facilitating a return to normalcy requires policy-driven strategies for schools and workplaces.
Purpose of the Study:
- To present the implementation of a novel tool for COVID-19 symptom and risk assessment.
- To evaluate the early performance of this return-to-work technology.
- To explore technology's role in managing workplace health during the pandemic.
Main Methods:
- Development and deployment of a symptom and risk assessment tool for COVID-19.
- Implementation within a return-to-work framework.
- Early-stage evaluation of the tool's effectiveness and user engagement.
Main Results:
- The tool provides an interface for symptom tracking and risk assessment.
- Early data suggests the tool can aid in managing workplace safety protocols.
- Implementation facilitated policy-driven approaches for returning to work environments.
Conclusions:
- Technological tools are vital for addressing pandemic-related challenges in occupational settings.
- The developed symptom and risk assessment tool shows promise for supporting safe return-to-work initiatives.
- Continued evaluation is necessary to optimize the tool's impact on public health and workplace normalcy.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128
Relative Risk
171
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
171
Hazard Ratio
124
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
124

